U.S. Markets closed

Evoke Pharma, Inc. (EVOK)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.61+0.05 (+1.95%)
At close: 4:00PM EDT
People also watch
HTBXEBIOMRNSZSANEYEG
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development6,951.68,154.1449,991.855
Selling General and Administrative3,592.8253,664.1593,158.179
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-10,544.425-11,818.303-13,150.034
Income from Continuing Operations
Total Other Income/Expenses Net63.92363.923-97.647
Earnings Before Interest and Taxes-10,748.531-12,121.463-13,247.681
Interest Expense---
Income Before Tax-10,748.531-12,121.463-13,247.681
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-10,748.531-12,121.463-13,247.681
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-10,748.531-12,121.463-13,247.681
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-10,748.531-12,121.463-13,247.681